中文部份
中央健康保險局 (2006a)。《全民健康保險醫事服務機構提供部分給付項目之作業原則》。
中央健康保險局(2006b)。《何謂部分給付》,摘自http://www.nhi.gov.tw /webdata/AttachFiles/ Attach_8419_2_何謂部分給付.pdf。
王昶閔 (2005,2005/08/21)。〈心血管藥物支架 貴但有效〉。《自由時報》。
行政院經濟建設委員會 (2006)。《台灣經濟永續發展會議實錄》。
行政院衛生署 (2007)。《衛生統計-歷年主要死亡原因死亡人數》。
行政院主計處 (2005)。《九十四年家庭收支調查報告》。 台北市: 行政院主計處。
李卓倫,紀駿輝,賴俊雄 (1995)。〈時間、所得與中西醫療價格對中醫門診利用之影響。《中華衛誌》, 14(6), 7。
李蜚鴻(2007)。〈塗藥血管支架高價差的省思〉。《健康世界》,(257),18-18。李樹人 (2006,2006/04/16)。〈醫師怕麻煩 少建議自費 害怕一開口建議換較好藥物 反被病人誣告惹來麻煩〉。《聯合晚報》。
林鴻儒,陳明豐 (2008)。〈急性冠心症治療的最新進展〉。《內科學誌》, 19, 91-102。盛竹玲 (2005, 2005/08/21)。〈總統支架 救他一命〉。《自由時報》。
許光宏,盧瑞芬 (1998)。〈全民健康保險藥品差額負擔可行性之研究〉。《行政院衛生署八十七年委託研究計畫報告》。
陳明豐 (2007)。《冠狀動脈心臟病與健康促進》。台北市: 健康文化。
黃瑞仁 (2008)。〈冠狀動脈心臟病的診斷與治療〉。《中華民國內膜異位症婦女協會會刊》, 15(2), 7-14。
劉中平、吳學明、高憲立(2008)。〈左主冠狀動脈疾病血管成形術之現況—藥物釋放型支架的影響〉。《內科學誌》,19,454-464。盧瑞芬,謝啟瑞 (2000)。《醫療經濟學 》(初版)。 臺北市: 學富文化事業公司。
蕭慶倫(2005)。〈台灣健保醫療科際利用與成本意涵之國際評估〉。《行政院衛生署九十三年委託研究計畫報告》。
韓幸紋、連賢明(2008)。〈降低部分負擔對幼兒醫療利用的影響:以北市兒童補助計畫為例〉。《經濟論文叢刊》,36(4),589-623。魏怡嘉 (2005, 2005/08/21)。〈為了保命不惜代價〉。《自由時報》。
英文部份
Charlson, M. E., Pompei, P., Ale s, K. L., MacKenzie, C. R. (1987). "A new method of classifying prognostic comorbidity in longitudinal studies: development and validation". J. Chronic Dis, 40(5), 373-383.
de Groot, V., Beckerman, H., Lankhorst, G. J., Bouter, L. M. (2003). "How to measure comorbidity a critical review of available methods". Journal of Clinical Epidemiology, 56(3), 221-229.
Elixhauser, A., Steiner, C., Harris, D. R., Coffey, R. M. (1998). "Comorbidity Measures for Use with Administrative Data". Medical Care, 36(1), 8-27.
Grootendorst, P. V., Marshall, J. K., Holbrook, A. M., Dolovich, L. R., O'Brien, B. J., Levy, A. R. (2005). "The Impact of Reference Pricing of Nonsteroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs". Health Services Research, 40(5p1), 1297-1317.
Ioannides-Demos, L., Ibrahim, J., McNeil, J. (2002). "Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes". PharmacoEconomics, 20(9), 577.
Kanavos, P., Reinhardt, U. (2003). "Reference Pricing For Drugs: Is It Compatible With US Health Care? " Health Affairs, 22(3), 16-30.
Laarman, G., Suttorp, M., Dirksen, M., van Heerebeek, L., Kiemeneij, F., Slagboom, T., et al. (2006). "Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention". New England Journal of Medicine, 355(11), 1105.
Lee, P., LeRoy, L., Ginsberg, P., Hammons, G. (1990). "Physician Payment Reform: An Idea Whose Time Has Come". Medical Care Research and Review, 47(2), 137.
Lynch, J., Kapalan, G. (2000). Socieconomic position. In L. Berkman I. Kawachi (Eds.), Social epidemiology: Oxford University Press New York.
Manning, W. G., Newhouse, J. P., Duan, N., Keeler, E. B., Leibowitz, A., Marquis, M. S. (1987). "Health Insurance and the Demand for Medical Care". American Economic Review, 77(3), 251-277.
Parng, I., Chen, L., Lee, C., Chou, Y. (2008, 2008/10/29 ). Impact of drug-eluting stents balance billing on Recipients and Treatment Outcome. Paper presented at the APHA 136th Annual Meeting and Exposition, CA. USA.
Philbin, E. F., McCullough, P. A., DiSalvo, T. G., Dec, G. W., Jenkins, P. L., Weaver, W. D. (2000). Socioeconomic Status Is an Important Determinant of the Use of Invasive Procedures After Acute Myocardial Infarction in New York State. Circulation, 102(90003), III-107-115.
Romano, P. S., Roos, L. L., Jollis, J. G. (1993). "Adapting a clinical comorbidity index for use with ICD-9-CM administrative data:differing perspectives". J Clin Epidemiol, 46(10), 1075.
Ryan, J., & Cohen, D. J. (2006). Drug-eluting stents: the price is not right. Circulation, 114(16), 1745.
Salomaa, V., Niemelä, M., Miettinen, H., Ketonen, M., Immonen-Räihä, P., Koskinen, S., et al. (2000). "Relationship of Socioeconomic Status to the Incidence and Prehospital, 28-Day, and 1-Year Mortality Rates of Acute Coronary Events in the FINMONICA Myocardial Infarction Register Study". Circulation, 101, 1913.
Schneeweiss, S. (2007). "Reference drug programs: Effectiveness and policy implications". Health Policy, 81(1), 17-28.
Schneeweiss , S., Seeger, J. D., Maclure , M. (2001). "Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data". American Journal of Epidemiology, 154(9).
Schneeweiss, S., Walker, A. M., Glynn, R. J., Maclure, M., Dormuth, C., Soumerai, S. B. (2002). "Outcomes of Reference Pricing for Angiotensin-Converting- Enzyme Inhibitors". The New England Journal of Medicine, 346(11), 822-829.
Shea, D., Terza, J., Stuart, B., Briesacher, B. (2007). "Estimating the Effects of Prescription Drug Coverage for Medicare Beneficiaries". Health Services Research, 42(3p1), 933-949.
Shen, Y., Hendricks, A., Wang, F., Gardner, J., Kazis, L. E. (2008). "The Impact of Private Insurance Coverage on Veterans' Use of VA Care: Insurance and Selection Effects". Health Services Research, 43(1p1), 267-286.
Smith, M. A., Nitz, N. M., Stuart, S. K. (2006). Severity and Comorbidity. In R. L. Kane (Ed.), Understanding Health Care Outcomes Research (2ed ed.): Jones and Bartlett Publishers.
Spaulding, C., Henry, P., Teiger, E., Beatt, K., Bramucci, E., Carrie, D., et al. (2006). "Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction". New England Journal of Medicine, 355(11), 1093.
Stukenborg, G. J., Wagner, D. P., Connors, A. F., Jr. (2001). "Comparison of the Performance of Two Comorbidity Measures, with and without Information from Prior Hospitalizations". Medical Care, 39(7), 727-739.
Von Korff, M., Wanger, E., Saunders, K. (1992). "A chronic disease score from automated pharmacy data". Journal of Clinical Epidemiology, 45(2), 197-203.
Weiner, J., Dr.P.H. (2005). The Johns Hopkins ACG® Case-Mix System Reference Manual Version 7.0, from http://www.acg.jhsph.edu/ACG Documents /RM_Version7_081905.pdf
WHO (2008). The top ten causes of death. from http://www.who.int/ mediacentre/factsheets/fs310_2008.pdf.
Yan, Y., Birman-Deych, E., Radford, M., Nilasena, D., Gage, B. (2005). "Comorbidity Indices to Predict Mortality From Medicare Data: Results From the National Registry of Atrial Fibrillation". Medical Care, 43(11), 1073.